Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report-Reference-Cited by-同舟云学术

Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report

Published:2020-09 Issue:5 Volume:63 Page:702-703
ISSN:0033-0620
Container-title:Progress in Cardiovascular Diseases
language:en
Short-container-title:Progress in Cardiovascular Diseases

Author:

Henry Brandon Michael,Benoit Stefanie,Lippi Giuseppe,Benoit Justin

Funder

University of Cincinnati College of Medicine

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Angiotensin-converting enzyme 2 and anti-hypertensives (angiotensin receptor blockers and angiotensin converting enzyme inhibitors) in coronavirus disease 2019 (COVID-19);Sanchis-Gomar;Mayo Clin Proc,2020

2. Clinical characteristics of Covid-19 in China;Henry;N Engl J Med,2020

3. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury;Kuba;Nat Med,2005

4. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury;Liu;Sci China Life Sci,2020

5. COVID-19, ACE2, and the cardiovascular consequences;South;Am J Physiol Heart Circ Physiol,2020

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic;Microorganisms;2024-03-14

2. Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial;eClinicalMedicine;2024-01

3. NOX2 and NOX5 are increased in cardiac microvascular endothelium of deceased COVID-19 patients;International Journal of Cardiology;2023-01

4. Serum Angiotensin II as a Biomarker in COVID-19;Biomarkers in Trauma, Injury and Critical Care;2023

5. Unquantifiably low aldosterone concentrations are prevalent in hospitalised COVID-19 patients but may not be revealed by chemiluminescent immunoassay;Endocrine Connections;2022-11-01